Winning Health(SZ:300253) Xin Lang Zheng Quan·2025-12-01 03:02Core Viewpoint - Weining Health's stock has shown fluctuations in recent trading sessions, with a year-to-date increase of 22.74% but a decline over the last 60 days of 12.91% [1] Financial Performance - For the period from January to September 2025, Weining Health reported a revenue of 1.296 billion yuan, a year-on-year decrease of 32.27%, and a net profit attributable to shareholders of -241 million yuan, reflecting a significant decline of 256.10% [2] - Cumulative cash dividends since the A-share listing amount to 455 million yuan, with 97.226 million yuan distributed over the last three years [3] Shareholder Structure - As of November 20, 2025, the number of Weining Health's shareholders decreased by 1.51% to 112,400, while the average circulating shares per person increased by 1.53% to 17,039 shares [2] - The top ten circulating shareholders include notable funds such as Huabao Zhongzheng Medical ETF and Yifangda Growth Mixed A, with some shareholders reducing their stakes [3] Stock Market Activity - On December 1, Weining Health's stock price reached 8.77 yuan per share, with a trading volume of 312 million yuan and a turnover rate of 1.89% [1] - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on February 7 [1] Business Overview - Weining Health, established on April 7, 2004, and listed on August 18, 2011, specializes in medical software development, sales, and technical services, providing comprehensive solutions for the healthcare industry's information technology needs [1] - The company's revenue composition includes 84.65% from software and services, 7.89% from hardware sales, and 7.46% from internet healthcare [1] Industry Classification - Weining Health is classified under the Shenwan industry category of Computer-Software Development-Vertical Application Software, and is associated with concepts such as AI models, domestic software, Alibaba Cloud, and DRG concepts [1]